Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 2/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25243264 | 0.92 | CTSL (0.50) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL25284441 | 0.92 | CTSL (0.50) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL25284440 | 0.92 | CTSL (0.50) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL19924761 | 0.89 | CTSL (0.42) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL19924760 | 0.89 | CTSL (0.42) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL19924759 | 0.89 | CTSL (0.42) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL25765470 | 0.89 | CTSL (0.53) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL29015557 | 0.89 | CTSL (0.53) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL29015558 | 0.81 | CTSL (0.48) | CTSLCAPN1CTSBCTSSCTSK | |
| SCHEMBL24190294 | 0.78 | CTSL (0.51) | CTSLCAPN1CTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165037-A1 | ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS | Aligos Therapeutics, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |